---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-037675"
form_type: "8-K"
ticker: "HLF"
cik: "0001180262"
company_name: "HERBALIFE LTD."
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:01:16.440011+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Herbalife Q1 net sales $1.2B (down 3.4% YoY), adjusted EBITDA $164.9M beats guidance

## Summary
- Net sales $1.2B at midpoint of guidance; down 3.4% YoY but up 1.4% on constant-currency basis.
- Net income $50.4M; adjusted net income $59.9M; diluted EPS $0.49, adjusted diluted EPS $0.59.
- Adjusted EBITDA $164.9M exceeds guidance; margin up 260 bps vs Q1 '24; leverage ratio reduced to 3.0x.
- Full-year 2025 guidance revised: net sales range narrowed, adjusted EBITDA raised, capex reduced.
- Completed acquisitions of Pro2col Health and Pruvit Ventures; formed HBL Link Bioscience with 51% ownership.

## SEC filing metadata
- accession: 0001213900-25-037675
- form_type: 8-K
- ticker: HLF
- cik: 0001180262
- company_name: HERBALIFE LTD.
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1180262/000121390025037675/0001213900-25-037675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1180262/000121390025037675/ea0240048-8k_herbalife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-037675
- JSON: https://secwatch.observer/filing/0001213900-25-037675.json
- Plain text: https://secwatch.observer/filing/0001213900-25-037675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.